Compare Budi Starch Sweetener Tbk (BUDI) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Budi Starch Sweetener Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 935.79B, 20.1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 20.1K). Which is the better fit depends on your goals.
| BUDI | DGNS | |
|---|---|---|
Market Cap | 935.79B | 310.75B |
Volume | 20.1K | 963.6K |
Lot | 201 | 9.64K |
Turnover | 4.18M | 217.67M |
Average Price | 207.72 | 225.89 |
Value | 4.18M | 217.67M |
Indicative Equilibrium Price | 208 | 226 |
Indicative Equilibrium Volume | 13.8K | 1K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Budi Starch Sweetener Tbk
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
